Project

Identification of microbial and cellular biomarkers for Short Bowel Syndrome in a combined in vitro-in vivo study

Acronym
SBS-microbe
Code
41U03422
Duration
01 January 2023 → 31 December 2024
Funding
European funding: framework programme, Regional and community funding: Special Research Fund
Research disciplines
  • Medical and health sciences
    • Microbial diagnostics
Keywords
malnutrition
Other information
 
Project description

Following extensive resection, the remaining small intestine may be of insufficient length to absorb nutrients, leading to short bowel syndrome (SBS). SBS is associated with significant malnutrition, and patients must take lifelong supplements. Funded by the Marie Skłodowska-Curie Actions programme, the SBS-microbe project aims to shed light on SBS pathogenesis, focusing on microbiota, metabolic and cellular changes occurring after resection. Researchers plan to develop in vitro models to study disease progression and the role of host−microbiota interactions. The identification of SBS drivers will unveil key targets for triggering intestinal homeostasis.

 
 
 
Disclaimer
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Union nor the authority can be held responsible for them.